Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis

被引：0
|
作者：
Holkova, Beata [1 ]
Tombes, Mary Beth [1 ]
Shrader, Ellen [1 ]
Cooke, Sheryl S. [2 ]
Wan, Wen [1 ]
Sankala, Heidi [1 ]
Kmieciak, Maciej [1 ]
Roberts, John D. [1 ]
Garcia-Manero, Guillermo [2 ]
Grant, Steven [1 ]
机构：
[1] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1115 / 1115
页数：1
相关论文
共 50 条
  • [1] Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis - One Year Update
    Holkova, Beata
    Bose, Prithviraj
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Weir-Wiggins, Caryn
    Stoddert, Elizabeth
    Sankala, Heidi
    Kmieciak, Maciej
    Roberts, John D.
    Garcia-Manero, Guillermo
    Grant, Steven
    BLOOD, 2012, 120 (21)
  • [2] Phase I study of pemetrexed in patients with relapsed or refractory acute leukemia or lymphoid blast phase chronic myelogenous leukemia
    Plunkett, W.
    Thomas, D. A.
    O'Brien, S. M.
    Federl, S.
    Giles, F. J.
    Nicol, S. J.
    Gill, J.
    Zhao, L.
    Ravandi, F.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Pevonedistat plus belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome: A phase I multicenter study
    Maher, Keri Renee
    Schafer, Danielle
    Schaar, Dale
    Sabo, Roy
    Bandyopadhyay, Dipankar
    Grant, Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome
    Maher, Keri R.
    Shafer, Danielle
    Schaar, Dale
    Bandyopadhyay, Dipankar
    Deng, Xiaoyan
    Wright, John
    Piekarz, Richard
    Rudek, Michelle A.
    Harvey, R. Donald
    Grant, Steven
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [5] Phase I trial of bortezomib, mitoxantrone and etoposide in relapsed/refractory acute leukemia
    Filicko-O'Hara, J.
    Mookerjee, B.
    Carabasi, M. H.
    Besa, E.
    Wagner, J. L.
    Flomenberg, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome
    Holkova, Beata
    Shafer, Danielle
    Yazbeck, Victor
    Dave, Sandeep
    Bose, Prithviraj
    Tombes, Mary Beth
    Shrader, Ellen
    Wan, Wen
    Bandyopadhyay, Dipankar
    Weir, Caryn
    Collins, Elizabeth B.
    Garnett, Amanda
    Kmieciak, Maciej
    Roberts, John D.
    Garcia-Manero, Guillermo
    Grant, Steven
    LEUKEMIA & LYMPHOMA, 2021, 62 (05) : 1187 - 1194
  • [7] A Phase I Study Using Single Agent Birinapant in Patients with Relapsed Myelodysplastic Syndrome and Acute Myelogenous Leukemia
    Frey, Noelle V.
    Luger, Selina
    Mangan, James
    Zebrowski, Alexis
    Loren, Alison W.
    Minderman, Hans
    Baird, John
    Porter, David L.
    Hexner, Elizabeth O.
    Kumar, Anita J.
    Luskin, Marlise R.
    Perl, Alexander E.
    Carroll, Martin
    BLOOD, 2014, 124 (21)
  • [8] Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia
    Klimek, Virginia M.
    Dolezal, Emily K.
    Smith, Larry
    Soff, Gerald
    Nimer, Stephen D.
    LEUKEMIA RESEARCH, 2012, 36 (05) : 570 - 574
  • [9] Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
    Kirschbaum, Mark
    Gojo, Ivana
    Goldberg, Stuart L.
    Kujawski, Lisa
    Atallah, Ehab
    Marks, Peter
    Garcia-Vargas, Jose
    Rizvi, Syed
    Di Gravio, Donna
    Ahern, Janet
    Issa, Jean-Pierre
    BLOOD, 2008, 112 (11) : 1250 - 1250
  • [10] Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia
    Liesveld, Jane L.
    O'Dwyer, Kristen
    Becker, Michael W.
    Mulford, Deborah
    Walker, Alison
    Chen, Rui
    Bechelli, Jeremy
    Rosell, Karen
    Jordan, Craig T.
    Minhajuddin, Mohammad
    Phillips, Gordon L., II
    BLOOD, 2012, 120 (21)
12345